• Pre-screening Questionnaire

    Thank you for your interest in the FIDELIO-DKD and FIGARO-DKD clinical research studies.

    The studies are evaluating the effects of an investigational medication when added to regular treatment for patients with type 2 diabetes and diabetic kidney disease (DKD). To see if you may be eligible, you will be asked a few questions. If you pre-qualify, the information you provide will be shared with the site conducting the study for which you may be eligible.

     

    Your privacy and personal information will always be protected.To learn more, please read our privacy policy.